Literature DB >> 17705063

Modulation of gene expression of three Cryptosporidium parvum ATP-binding cassette transporters in response to drug treatment.

Alvaro J Benitez1, Nina McNair, Jan Mead.   

Abstract

We studied three ATP-binding cassette (ABC) transporters (cgd1_1350, cgd7_4510, and cgd7_4520) of Cryptosporidium parvum that were identified to share a high level of homology with nucleotide binding domains of other parasitic ABC transporters and therefore could be potential candidates of efflux of drugs and/or contribute to the intrinsic resistance to chemotherapy observed of this parasite. Partial characterization and expression analysis of three C. parvum ABC transporters was determined by standard semi-quantitative real-time polymerase chain reaction. Expression of mRNA of the three ABC transporters was detected at different time points in infected cell cultures over the 48-h period, corresponding to the development of the sexual and asexual stages of the parasite. To determine if these three transporters were modulated in response to drug treatment, infected HCT 8 cells were then incubated for 48 h with different concentrations of paromomycin and a single concentration of cyclosporin A. Our results indicated that treatment by paromomycin resulted in approximately five to eightfold upregulation of cgd1_1350 transcript and about threefold of upregulation of Cgd7_4510 transcript levels. Cyclosporin A had a similar upregulating effect on cgd1_1350 and cgd7_4510 RNA levels: fivefold and 2.6-fold, respectively. On the contrary, drug treatment had little effect on cgd7_4520 transcript levels. Therefore, two of these transporters may be of value as tools for the study and the rational drug design of specific inhibitors to counteract C. parvum's intrinsic drug resistance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17705063     DOI: 10.1007/s00436-007-0701-x

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  15 in total

1.  The Cryptosporidium parvum ABC protein family.

Authors:  Fernando Zapata; Margaret E Perkins; Ynolde A Riojas; Teresa W Wu; Sylvie M Le Blancq
Journal:  Mol Biochem Parasitol       Date:  2002-03       Impact factor: 1.759

Review 2.  Emerging public health concerns regarding cryptosporidiosis.

Authors:  P K Saini; G Ransom; A M McNamara
Journal:  J Am Vet Med Assoc       Date:  2000-09-01       Impact factor: 1.936

Review 3.  Current therapeutic approaches to cryptosporidiosis in immunocompromised patients.

Authors:  A I Hoepelman
Journal:  J Antimicrob Chemother       Date:  1996-05       Impact factor: 5.790

4.  Cyclosporin analogs inhibit in vitro growth of Cryptosporidium parvum.

Authors:  M E Perkins; T W Wu; S M Le Blancq
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

Review 5.  Inventory and function of yeast ABC proteins: about sex, stress, pleiotropic drug and heavy metal resistance.

Authors:  B E Bauer; H Wolfger; K Kuchler
Journal:  Biochim Biophys Acta       Date:  1999-12-06

Review 6.  The MDR superfamily of genes and its biological implications.

Authors:  S Childs; V Ling
Journal:  Important Adv Oncol       Date:  1994

7.  Aminoglycoside antibiotics and eukaryotic protein synthesis: stimulation of errors in the translation of natural messengers in extracts of cultured human cells.

Authors:  J M Wilhelm; J J Jessop; S E Pettitt
Journal:  Biochemistry       Date:  1978-04-04       Impact factor: 3.162

8.  A chemiluminescence immunoassay for evaluation of Cryptosporidium parvum growth in vitro.

Authors:  X You; M J Arrowood; M Lejkowski; L Xie; R F Schinazi; J R Mead
Journal:  FEMS Microbiol Lett       Date:  1996-03-01       Impact factor: 2.742

9.  Correlation between the affinity of flavonoids binding to the cytosolic site of Leishmania tropica multidrug transporter and their efficiency to revert parasite resistance to daunomycin.

Authors:  J M Pérez-Victoria; M J Chiquero; G Conseil; G Dayan; A Di Pietro; D Barron; S Castanys; F Gamarro
Journal:  Biochemistry       Date:  1999-02-09       Impact factor: 3.162

10.  Drug binding to P-glycoprotein is inhibited in normal tissues following SDZ-PSC 833 treatment.

Authors:  L Jetté; G F Murphy; R Béliveau
Journal:  Int J Cancer       Date:  1998-05-29       Impact factor: 7.396

View more
  7 in total

1.  A nanotherapy strategy significantly enhances anticryptosporidial activity of an inhibitor of bifunctional thymidylate synthase-dihydrofolate reductase from Cryptosporidium.

Authors:  Anindita Mukerjee; Pinar Iyidogan; Alejandro Castellanos-Gonzalez; José A Cisneros; Daniel Czyzyk; Amalendu Prakash Ranjan; William L Jorgensen; A Clinton White; Jamboor K Vishwanatha; Karen S Anderson
Journal:  Bioorg Med Chem Lett       Date:  2015-04-04       Impact factor: 2.823

Review 2.  Understanding drug resistance in human intestinal protozoa.

Authors:  Hend Aly El-Taweel
Journal:  Parasitol Res       Date:  2015-03-19       Impact factor: 2.289

3.  Prodrug activation by Cryptosporidium thymidine kinase.

Authors:  Xin E Sun; Lisa Sharling; Mani Muthalagi; Devaraja G Mudeppa; Krzysztof W Pankiewicz; Krzysztof Felczak; Pradipsinh K Rathod; Jan Mead; Boris Striepen; Lizbeth Hedstrom
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

4.  Elucidation of cellular mechanisms involved in experimental paromomycin resistance in Leishmania donovani.

Authors:  Vasundhra Bhandari; Shyam Sundar; Jean Claude Dujardin; Poonam Salotra
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

5.  Cryptosporidiosis-an overview.

Authors:  Gordon J Leitch; Qing He
Journal:  J Biomed Res       Date:  2012-02-21

6.  Cloning and Iron Transportation of Nucleotide Binding Domain of Cryptosporidium andersoni ATP-Binding Cassette (CaABC) Gene.

Authors:  Ju-Hua Wang; Xiu-Heng Xue; Jie Zhou; Cai-Yun Fan; Qian-Qian Xie; Pan Wang
Journal:  Korean J Parasitol       Date:  2015-06-30       Impact factor: 1.341

7.  P-Glycoprotein-Mediated Efflux Reduces the In Vivo Efficacy of a Therapeutic Targeting the Gastrointestinal Parasite Cryptosporidium.

Authors:  Samuel L M Arnold; Ryan Choi; Matthew A Hulverson; Grant R Whitman; Molly C Mccloskey; Carlie S Dorr; Rama S R Vidadala; Mansi Khatod; Mary Morada; Lynn K Barrett; Dustin J Maly; Nigel Yarlett; Wesley C Van Voorhis
Journal:  J Infect Dis       Date:  2019-08-30       Impact factor: 5.226

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.